Mitochondrial Regulation of Hematopoietic Stem Cells
造血干细胞的线粒体调节
基本信息
- 批准号:10551891
- 负责人:
- 金额:$ 67.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-01-17 至 2025-12-31
- 项目状态:未结题
- 来源:
- 关键词:AllelesAnemiaApoptosisAreaAttenuatedBiogenesisBlood CellsBone MarrowBone Marrow CellsBuffersCalciumCell CompartmentationCell MaintenanceCellsCellular biologyEndowmentEnvironmentEpigenetic ProcessFetal LiverFundingGeneticGlycolysisGoalsGuanosine Triphosphate PhosphohydrolasesHematological DiseaseHematopoiesisHematopoieticHematopoietic SystemHematopoietic stem cellsIn VitroIndividualInterferon alphaInterferonsLymphoidMaintenanceMalignant - descriptorMediatingMembraneMetabolismMitochondriaMolecularMusNeonatal MortalityOPA1 geneOrganellesPerinatal mortality demographicsPhenotypePlayProcessProductionPublishingRegulationRespirationRoleSTAT1 geneSignal InductionSignal TransductionSiteTestingepigenetic regulationexperimental studyfunctional disabilityhematopoietic stem cell expansionhematopoietic stem cell quiescencemicrobiomemitochondrial metabolismmutantnovel strategiesnuclear factors of activated T-cellsprogenitorreconstitutionresponseself-renewalsmall moleculestem cell biologystem cells
项目摘要
Hematopoietic stem cells (HSCs) reside in the bone marrow (BM), are quiescent, can self-renew, and generate
all lineages of the hematopoietic system. A coherent picture of how steady-state function and homeostatic
responses of HSCs are regulated has not emerged yet, however. Furthermore, although progress has been
made in this area, reliable renewal or even maintenance of HSCs in vitro remains challenging, but would have
major translational implications. A particular gap is our understanding of the organellar cell biology of HSCs. One
organelle of which role in HSCs is unclear is the mitochondrion. Preferential use of glycolysis in stem cells
suggests that mitochondrial respiration is more dispensable for HSCs than for progenitors. These findings raise
the question whether mitochondria play roles in HSCs that are not directly related to ATP production, such as
intermediary metabolism, epigenetics, apoptosis and intracellular calcium handling. Mitochondria dynamics, the
fusion and fission of mitochondria, play a central role in the coordination of mitochondrial function. The fusion
machinery consists of two partially redundant and interacting outer membrane GTPases, mitofusins (MFN) 1
and 2, and the inner membrane GTPase, OPA1. We observed that mitofusins show redundant and non-
redundant as well as cell-intrinsic and cell-extrinsic roles that profoundly and specifically impact HSCs. We also
found that HSCs are endowed with elevated mitochondrial mass and attenuated mitophagy, and that all mitofusin
mutants with severe phenotypes also had reduced mitochondrial mass in HSCs, but not in mature hematopoietic
cells. The goal of this proposal is to elucidate the underlying mechanisms and harness mitochondrial dynamics
to achieve more efficient maintenance of HSC in vitro.
造血干细胞(HSCs)驻留在骨髓(BM)中,处于静止状态,可以自我更新和生成
造血系统的所有血统。一幅关于稳态功能和动态平衡的连贯图景
然而,HSCs的反应受到调控还没有出现。此外,尽管取得了进展,但
在这一领域制造,可靠的更新,甚至在体外维持造血干细胞仍然具有挑战性,但将
主要的翻译含义。一个特别的差距是我们对HSCs的细胞器细胞生物学的理解。一
线粒体在HSCs中的作用尚不清楚。干细胞糖酵解的优先使用
这表明线粒体呼吸对造血干细胞比对祖细胞更可有可无。这些发现提出了
线粒体是否在HSCs中扮演与ATP产生没有直接关系的角色,例如
中间代谢、表观遗传学、细胞凋亡和细胞内钙处理。线粒体动力学,即
线粒体的融合和分裂,在线粒体功能的协调中起着核心作用。核聚变
机械由两个部分冗余和相互作用的外膜GTP酶组成,即有丝分裂素(MFN)1
和2,以及内膜GTP酶OPA1。我们观察到,有丝分裂素显示出冗余和非
以及细胞内部和细胞外部的冗余角色,对HSC产生深远而具体的影响。我们也
发现HSCs具有线粒体质量增加和有丝分裂功能减弱的特点,并且所有的有丝分裂蛋白
具有严重表型的突变体也减少了HSCs中的线粒体质量,但在成熟的造血细胞中则没有
细胞。这项提议的目的是阐明潜在的机制和利用线粒体动力学。
以实现HSC在体外更有效的维护。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HANS-WILLEM E SNOECK其他文献
HANS-WILLEM E SNOECK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HANS-WILLEM E SNOECK', 18)}}的其他基金
Leica Stellaris 8 Confocal Microscope
Leica Stellaris 8 共焦显微镜
- 批准号:
10431426 - 财政年份:2022
- 资助金额:
$ 67.57万 - 项目类别:
Lung epithelial cell specification in human pluripotent stem cells
人多能干细胞的肺上皮细胞规格
- 批准号:
10378129 - 财政年份:2019
- 资助金额:
$ 67.57万 - 项目类别:
Lung epithelial cell specification in human pluripotent stem cells
人多能干细胞的肺上皮细胞规格
- 批准号:
9902521 - 财政年份:2019
- 资助金额:
$ 67.57万 - 项目类别:
Mitochondrial Maintenance Mechanisms of Stem Cells and Aging
干细胞的线粒体维持机制与衰老
- 批准号:
9751137 - 财政年份:2017
- 资助金额:
$ 67.57万 - 项目类别:
Mitochondrial Maintenance Mechanisms of Stem Cells and Aging
干细胞的线粒体维持机制与衰老
- 批准号:
10192621 - 财政年份:2017
- 资助金额:
$ 67.57万 - 项目类别:
Mitochondrial Regulation of Hematopoietic Stem Cells
造血干细胞的线粒体调节
- 批准号:
10375950 - 财政年份:2017
- 资助金额:
$ 67.57万 - 项目类别:
Mitochondrial regulation of hematopoietic stem cells
造血干细胞的线粒体调控
- 批准号:
9218717 - 财政年份:2017
- 资助金额:
$ 67.57万 - 项目类别:
Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis
特发性肺纤维化的建模、发病机制和治疗
- 批准号:
9516638 - 财政年份:2016
- 资助金额:
$ 67.57万 - 项目类别:
Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis
特发性肺纤维化的建模、发病机制和治疗
- 批准号:
9509525 - 财政年份:2016
- 资助金额:
$ 67.57万 - 项目类别:
Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis
特发性肺纤维化的建模、发病机制和治疗
- 批准号:
10416013 - 财政年份:2016
- 资助金额:
$ 67.57万 - 项目类别:
相似国自然基金
基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
- 批准号:82302715
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
- 批准号:
- 批准年份:2021
- 资助金额:10.0 万元
- 项目类别:省市级项目
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
- 批准号:31200592
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigation of crosstalk between Fanconi Anemia pathway and ATM for novel therapeutic strategies of chemoresistant ALT-positive high-risk neuroblastoma
范可尼贫血通路与 ATM 之间的串扰研究,用于化疗耐药 ALT 阳性高危神经母细胞瘤的新治疗策略
- 批准号:
24K10442 - 财政年份:2024
- 资助金额:
$ 67.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Immune escape mechanisms in BCOR/BCORL1 mutant hematopoietic stem cells from patients with aplastic anemia
再生障碍性贫血患者 BCOR/BCORL1 突变型造血干细胞的免疫逃逸机制
- 批准号:
23K15297 - 财政年份:2023
- 资助金额:
$ 67.57万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Fanconi anemia経路に着目したiPS細胞における高レベル複製ストレスの原因解明
阐明 iPS 细胞中高水平复制应激的原因,重点关注范可尼贫血途径
- 批准号:
23K14452 - 财政年份:2023
- 资助金额:
$ 67.57万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Analysis of the mechanism of hemolytic anemia in canine babesiosis and development of novel therapeutic measures
犬巴贝斯虫病溶血性贫血机制分析及新治疗措施开发
- 批准号:
23KJ0074 - 财政年份:2023
- 资助金额:
$ 67.57万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Mobile phone-based screening for anemia in young children in western Kenya
基于手机的肯尼亚西部幼儿贫血筛查
- 批准号:
10752968 - 财政年份:2023
- 资助金额:
$ 67.57万 - 项目类别:
Brain blood flow, oxygenation, and cognition in adult onset iron deficiency anemia
成人缺铁性贫血的脑血流量、氧合和认知
- 批准号:
10735765 - 财政年份:2023
- 资助金额:
$ 67.57万 - 项目类别:
Chromatin State Alterations in Fanconi Anemia Hematologic Disease and Bone Marrow Failure
范可尼贫血血液疾病和骨髓衰竭中的染色质状态改变
- 批准号:
10735366 - 财政年份:2023
- 资助金额:
$ 67.57万 - 项目类别:
Accuracy and Feasibility of Non-Invasive Anemia Screening Assistant (ASIST) Device in Resource-Limited Settings
资源有限环境中非侵入性贫血筛查辅助 (ASIST) 设备的准确性和可行性
- 批准号:
10575222 - 财政年份:2023
- 资助金额:
$ 67.57万 - 项目类别:
Liver-Gut Axis in Neonatal Anemia and Its Role in RBC Transfusion Associated Gut Injury
新生儿贫血中的肝肠轴及其在红细胞输注相关肠道损伤中的作用
- 批准号:
10583807 - 财政年份:2023
- 资助金额:
$ 67.57万 - 项目类别:
A Sample-to-Answer Point-of-Care Diagnostic for Recently Transfused Sickle Cell Anemia Patients in Low Resource Settings
针对资源匮乏地区最近输血的镰状细胞性贫血患者的从样本到答案的护理点诊断
- 批准号:
10564553 - 财政年份:2023
- 资助金额:
$ 67.57万 - 项目类别:














{{item.name}}会员




